---
type: "Symbol"
title: "Mainz Biomed NV (MYNZ.US) — Community Discussions"
description: "Community discussions about this stock, including analyst opinions, earnings analysis, and investment strategies from verified financial professionals and active investors."
locale: "en"
url: "https://longbridge.com/en/quote/MYNZ.US/topics.md"
symbol: "MYNZ.US"
parent: "https://longbridge.com/en/quote/MYNZ.US.md"
count: 2
datetime: "2026-03-08T06:26:43.894Z"
locales:
  - [en](https://longbridge.com/en/quote/MYNZ.US/topics.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MYNZ.US/topics.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MYNZ.US/topics.md)
---

# Mainz Biomed NV (MYNZ.US) — Community Discussions

### [$Mainz Biomed NV(MYNZ.US) folks are here](https://longbridge.com/en/topics/36341572.md)

- Author: [勇敢明明](https://longbridge.com/en/profiles/21744076.md)
- Datetime: 2025-11-13T17:25:33.000Z
- Comments: 2
- $Mainz Biomed NV(MYNZ.US) folks are here

**Comments:**

- **抖音梁策手机数码 · 2025-11-14T11:25:23.000Z**: No movement today

### [阿浦美股百科 | 癌症早期筛查诊断新产品 – MAINZ BIOMED](https://longbridge.com/en/topics/1490528.md)

- Author: [阿浦美股](https://longbridge.com/en/profiles/6844605.md)
- Datetime: 2021-12-09T12:30:52.000Z
- Comments: 1
- 01 企业介绍 MAINZBIOMED B.V.$Mainz Biomed NV(MYNZ.US) 于 2021 年 3 月 8 日在荷兰注册成立，为创立于 2008 年的德国公司。2021 年收购了德国公司 PharmGenomicsGmbH，目的为在欧洲与美国实现商业化。PharmGenomics 为一家已经取得德国 DIN EN ISO 认证的体外诊断（IVD）制造商...

**Comments:**

- **nozt3e · 2021-12-12T01:47:05.000Z**: 醫療股仍然有優勢

## References

- [Mainz Biomed NV (MYNZ.US)](https://longbridge.com/en/quote/MYNZ.US.md)


> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/MYNZ.US/topics.md) | [繁體中文](https://longbridge.com/zh-HK/quote/MYNZ.US/topics.md)